awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q45108007-2D281430-3F7A-4C6B-AD2C-C5035BF4FFA0
Q45108007-2D281430-3F7A-4C6B-AD2C-C5035BF4FFA0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45108007-2D281430-3F7A-4C6B-AD2C-C5035BF4FFA0
Levosimendan improves LV systolic and diastolic performance at rest and during exercise after heart failure.
P2860
Q45108007-2D281430-3F7A-4C6B-AD2C-C5035BF4FFA0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45108007-2D281430-3F7A-4C6B-AD2C-C5035BF4FFA0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c1e66e5aea59c705ee83f6bc285ead64d0b9c41e
P2860
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.